Rates of venous thromboembolism among patients with major surgery for cancer

Annals of Surgical Oncology

Volumn 18, Issue 12, 2011, Pages 3240-3247

  Hammond, Jeffrey ^a   Kozma, Chris ^b   Hart, James C ^a   Nigam, Somesh ^c   Daskiran, Mehmet ^c   Paris, Andrew ^d   Mackowiak, John I ^e  

^a ETHICON INC   (United States)

^b CK Consulting   (United States)

^c JOHNSON AND JOHNSON   (United States)

^d Vigilytics   (United States)

^e Center for Outcomes Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; DALTEPARIN; DIPYRIDAMOLE; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE;

ARTICLE; CANCER SURGERY; COLON RESECTION; DATA BASE; ESOPHAGUS RESECTION; GASTRECTOMY; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; INFORMATION; LUNG RESECTION; MEDICARE; NEPHRECTOMY; OUTPATIENT; PHARMACY; POSTOPERATIVE PERIOD; PROPHYLAXIS; PROSTATECTOMY; RISK BENEFIT ANALYSIS; SENSITIVITY ANALYSIS; SURGEON; SURGICAL PATIENT; SURGICAL TECHNIQUE; UNITED STATES; VENOUS THROMBOEMBOLISM;

FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOEMBOLISM;

EID: 83055188406     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1723-2     Document Type: Article

References (14)

1. AHRQ. Patient safety indicators. http://qualityindicators.ahrq.gov/ downloads/psi/2006-Feb-PatientSafetyIndicators.pdf (2006). Accessed 20 Nov. 2009.
2. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism. Arch Internal Med. 1998;15:585-93.
3. Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med. 2000;160(22):3431-6.
4. Edelsberg J, Hagiwara M, Taneja C, Oster G. Risk of venous thromboembolism among hospitalized medically ill patients. Am J Health Syst Pharm. 2006;63(20 Suppl 6):S16-22.
5. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):19):19-16.
6. Sweetland S, Green J, Liu B, et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ. 2009:339: b4583 doi: 10:1136/bmj.b4583.
7. Hitos K, Fletcher JP. Venous thromboembolism following primary total knee arthroplasty. Int Angiol. 2006:25(4):343-51.
8. Rasmussen MS, Jorgenssen LN, Willie-Jorgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2009; (1): CD004318.
9. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th edn. Chest. 2008;133(6 Suppl):381S-453S.
10. Khorana AA, Streiff MB, Farge D, et al. Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. J Clin Oncol. 2009;27:4919-26.
11. Khoranna AA, Francis CW, Culakova E, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007;110:2339-46.
12. Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors. Determination of frequency and characteristics. Thromb Haemost. 2002;87:575-9.
13. Leibson CL, Needleman J, Buerhaus P, Heit JA, Melton LJ 3rd, Naessens JM, Bailey KR, Petterson TM, Ransom JE, Harris MR. Identifying in-hospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE Cohort. Medical Care. 2008;46:127-32.
14. Zhan C, Battles J, Chiang YP, et al. The validity of ICD-9-CM codes in identifying postoperative deep vein thrombosis and pulmonary embolism. Jt Comm J Qual Patient Sat. 2007;33(6):326-31.